v3.5.0.2
NOTE 6 - STOCKHOLDERS' EQUITY (Tables)
9 Months Ended
Sep. 30, 2016
Stockholders' Equity Note [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] The following assumptions were used in determining the fair value of employee and vesting non-employee options during the nine months ended September 30, 2016 and 2015:

 
September 30,
2016
 
September 30,
2015
 
Risk-free interest rate
 
 
1.38% - 1.73
%
 
 
1.68% - 2.07
%
Dividend yield
 
 
0
%
 
 
0
%
Stock price volatility
 
 
129.41%-134.81
%
 
 
123.08% -145.24
%
Expected life
5 – 9.9 years
 
5-10 years
 
Weighted average grant date fair value
 
$
0.94
 
 
$
5.90
 
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] The following table summarizes the stock option activity for the nine months ended September 30, 2016:

 
 
Shares
   
Weighted-Average
Exercise Price
   
Weighted Average
Remaining
Contractual Term
 
Aggregate
Intrinsic Value
 
Outstanding at January 1, 2016
   
629,628
   
$
7.59
     
4.5
     
Granted
   
388,495
   
$
1.28
     
10.0
     
Canceled/expired
                           
Outstanding at September 30, 2016
   
1,018,123
   
$
5.18
     
5.9
   
$
50
 
 
                               
Exercisable at September 30, 2016
   
905,854
   
$
5.28
     
5.5
   
$
4
 
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] The following table presents information related to stock options at September 30, 2016:

Options Outstanding
   
Options Exercisable
 
Exercise
Price
   
Number of
Options
   
Weighted Average
Remaining Life
In Years
   
Exercisable
Number of
Options
 
$
0.00-5.00
     
611,440
     
7.5
     
552,169
 
 
5.01-12.50
     
382,675
     
3.6
     
329,677
 
 
12.51-25.00
     
15,008
     
3.5
     
15,008
 
 
25.01-45.00
     
9,000
     
3.1
     
9,000
 
         
1,018,123
     
5.9
     
905,854
 
Schedule of Outstanding Warrants [Table Text Block] The following table summarizes information with respect to outstanding warrants to purchase common stock of the Company, all of which were exercisable, at September 30, 2016:

Exercise
Price
   
Number
Outstanding
 
Expiration Date
$
1.25
   
$
117,648
 
March 2021
 
2.13
     
609,756
 
April 2021
 
4.75
     
482,500
 
Sept/Oct 2020
         
1,209,904
 
 
Schedule of Warrants Activity [Table Text Block] The following table summarizes the warrant activity for the nine months ended September 30, 2016:

 
 
Shares
   
Weighted-Average
Exercise Price
   
Weighted-Average
Remaining
Contractual Term
 
Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2016
   
703,413
   
$
4.83
     
3.5
     
Grants
   
727,404
   
$
1.99
     
5.0
     
Exercised
   
-
                     
Forfeitures or expirations
   
(220,913
)
 
$
5.00
             
Outstanding at September 30, 2016
   
1,209,904
   
$
3.09
     
4.3
   
$
-
 
 
                               
Exercisable at September 30, 2016
   
1,209,904
   
$
3.09
     
4.3
   
$
-